ArticleEye (London, England)2016

Response to: Comment on 'Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS'.

A Salmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.